• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: MEDTRONIC PERMANENT DEFIBRILLATOR ELECTRODES

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

MEDTRONIC PERMANENT DEFIBRILLATOR ELECTRODES Back to Search Results
Model Number 5076
Device Problems Failure to Sense (1559); Loss of Threshold (1633)
Patient Problem Insufficient Information (4580)
Event Type  malfunction  
Event Description
This ra lead was implanted on (b)(6)2010 and remains implanted at this time.A product experience report received on (b)(6) 2017 stated that on (b)(6) 2017 there was a loss of sensing and pacing thershold was hig on ra lead.No x-ray confirmation of lead placment in header, physician advised to carry out to determine correct connection.Lead impedance remains within normal limits.Planning for revision procedure.The physician was dr.Peter o'callaghan at university hospita of wales in cardiff , united kingdom.No other information available.This report reflects information received by fda in the form of a notification per 803.22 (b)(2).
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
PERMANENT DEFIBRILLATOR ELECTRODES
Type of Device
PERMANENT DEFIBRILLATOR ELECTRODES
Manufacturer (Section D)
MEDTRONIC
MDR Report Key17529211
MDR Text Key321050545
Report NumberMW5136140
Device Sequence Number1
Product Code NVY
Combination Product (y/n)N
Number of Events Reported1
Summary Report (Y/N)N
Report Source Voluntary
Reporter Occupation Other
Type of Report Initial
Report Date 08/30/2017
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? No
Device Model Number5076
Initial Date Manufacturer Received Not provided
Initial Date FDA Received08/12/2023
Patient Sequence Number1
-
-